ヒトiPS細胞から後脳特異的な神経幹細胞を安定的に誘導・維持する手法を開発 ー 後脳の発達解明や神経変性疾患の病態解明・創薬研究への貢献に期待 ー

ad

2026-03-31 京都大学iPS細胞研究所

京都大学iPS細胞研究所(CiRA)などの研究グループは、ヒトiPS細胞から後脳特異的な神経幹細胞(Hb-LiNSCs)を安定的に誘導・長期維持する新手法を開発した。3種の低分子化合物(ACLカクテル)により、動物由来成分や成長因子を使わず短期間で誘導可能とし、1年以上にわたり後脳の領域特異性と正常な性質を維持できることを実証した。さらに分化した神経細胞は機能的ネットワークを形成し、マウス脳内でも生着・分化した。本技術は後脳疾患の病態解明や創薬研究に有用な安定的細胞モデルを提供する。

ヒトiPS細胞から後脳特異的な神経幹細胞を安定的に誘導・維持する手法を開発 ー 後脳の発達解明や神経変性疾患の病態解明・創薬研究への貢献に期待 ー
本研究の概要

<関連情報>

hiPSCからの後脳様神経幹細胞の誘導および維持のためのWnt活性化と二重SMAD阻害 Wnt activation and dual SMAD inhibition for induction and maintenance of hindbrain-like neural stem cell from hiPSCs

Ziadoon Al-Akashi ∙ Denise Zujur ∙ Nicholas Boyd-Gibbins ∙ … ∙ Asuka Morizane, ∙ Jun Takahashi ∙ Makoto Ikeya
Cell Reports Methods  Published:March 30, 2026
DOI:https://doi.org/10.1016/j.crmeth.2026.101372

Motivation

The extraction and expansion of human hindbrain stem cells from human embryos have been reported; however, such methods do not allow cell extraction from patients because of the critical anatomical location and associated ethical constraints. Therefore, we sought to induce human iPSCs into hindbrain-like neural stem cells under minimal conditions that enable scalability and reproducibility.

Highlights

  • Hindbrain-like NSCs (Hb-LiNSCs) were induced from hiPSCs using small molecules
  • The protocol is xeno- and bFGF-free and ensures high reproducibility
  • Hb-LiNSCs maintain regional identity and potency for over 60 weeks of culture
  • Differentiated neurons from Hb-LiNSCs show functional network activity in vitro

Summary

Neurons exhibit region-specific identities corresponding to functional distinctions across different brain areas. Region-restricted neural stem cells (NSCs) have previously been generated from pluripotent stem cells; however, maintaining their regional identity over extended passages remains challenging. Here, we report the generation of hindbrain-like induced NSCs (Hb-LiNSCs) with upregulated hindbrain-specific markers and downregulated forebrain, midbrain, and spinal cord markers under xeno-free and basic fibroblast growth factor (bFGF)-free conditions using three chemicals—CHIR99021 (at a high concentration), a potent activator of the Wnt pathway; A-83-01, a potent inhibitor of the TGF-β/Activin/Nodal pathway; and LDN193189, a potent inhibitor of the bone morphogenetic protein pathway. Hb-LiNSCs maintained their chromosomal integrity, multipotency, and differentiation capacity even after long-term culture for more than 60 weeks. This approach enhances our understanding of neurodevelopmental and neurodegenerative processes in the hindbrain region and paves the way for developing targeted cell-based therapy as well as disease modeling for drug discovery.

細胞遺伝子工学
ad
ad
Follow
ad
タイトルとURLをコピーしました